Cytoplasmic Expression of TP53INP2 Modulated by Demethylase FTO and Mutant NPM1 Promotes Autophagy in Leukemia Cells
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24021624 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Junpeng Huang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, College of Laboratory Medicine, Chongqing Medical Universit…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Nuclear Proteins. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of CQ CSTC, Natural Science Foundation of Chongqing.
Abstract (Originalsprache)
Acute myeloid leukemia (AML) with a nucleophosmin 1 (NPM1) mutation is a unique subtype of adult leukemia. Recent studies show that NPM1-mutated AML has high autophagy activity. However, the mechanism for upholding the high autophagic level is still not fully elucidated. In this study, we first identified that tumor protein p53 inducible nuclear protein 2 (TP53INP2) was highly expressed and cytoplasmically localized in NPM1-mutated AML cells. Subsequent data showed that the expression of TP53INP2 was upregulated by fat mass and obesity-associated protein (FTO)-mediated m6A modification. Meanwhile, TP53INP2 was delocalized to the cytoplasm by interacting with NPM1 mutants. Functionally, cytoplasmic TP53INP2 enhanced autophagy activity by promoting the interaction of microtubule-associated protein 1 light chain 3 (LC3) - autophagy-related 7 (ATG7) and further facilitated the survival of leukemia cells. Taken together, our study indicates that TP53INP2 plays an oncogenic role in maintaining the high autophagy activity of NPM1-mutated AML and provides further insight into autophagy-targeted therapy of this leukemia subtype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Laboratory Medical Diagnostics Designated by the Ministry of Education, College of Laboratory Medicine, Chongqing Medical University, No. 1, Yixueyuan Road, Chongqing 400016, China.
- Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Cancer Hospital, Chongqing University, Chongqing 400030, China.
ORCID-Profile: Ling Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of CQ CSTC
- Natural Science Foundation of Chongqing
Zitieren
APA
Huang, J., Sun, M., Tao, Y., Ren, J., Peng, M., Jing, Y., Xiao, Q., Yang, J., Lin, C., Lei, L., Yang, Z., & Zhang, L. (2023). Cytoplasmic Expression of TP53INP2 Modulated by Demethylase FTO and Mutant NPM1 Promotes Autophagy in Leukemia Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021624
Vancouver
Huang J, Sun M, Tao Y, Ren J, Peng M, Jing Y, et al. Cytoplasmic Expression of TP53INP2 Modulated by Demethylase FTO and Mutant NPM1 Promotes Autophagy in Leukemia Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021624
BibTeX
@article{Huang2023,
author = {Huang, Junpeng and Sun, Minghui and Tao, Yonghong and Ren, Jun and Peng, Meixi and Jing, Yipei and Xiao, Qiaoling and Yang, Jing and Lin, Can and Lei, Li and Yang, Zailin and Zhang, Ling},
title = {Cytoplasmic Expression of TP53INP2 Modulated by Demethylase FTO and Mutant NPM1 Promotes Autophagy in Leukemia Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24021624}
}
EUVIMED